bicalutamide
Ligand Summary
Bicalutamide is a non-steroidal androgen receptor inhibitor. It competitively inhibits the action of androgens by binding to cytosol androgen receptors in the target tissue. Prostatic carcinoma is known to be androgen sensitive and responds to treatment that counteracts the effect of androgen and/or removes the source of androgen.
UNII: A0Z3NAU9DP
PubChem: 2375
Guide to Pharmacology: 2863
ChEMBL: CHEMBL409
DrugCentral: 367
LyCHI: TS19J1PB4SYJ
Target Activities
20 Activities
Items per page:
1 – 10 of 20
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | ||||||
Ki | ||||||
Ki | ||||||
EC50 | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
Ki | ||||||